CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 5 Insider Annual Insider Trading Report
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 5 Insider Annual Insider Trading Report
- 4 Option exercise Director acquired 114,250 shares (option exercise)
- 8-K Event Material agreement
- SC 13D/A Stake Beneficial Ownership Report
- 4 Grant or award Director acquired 58,140 shares (grant or award)
- 4 Grant or award Director acquired 5,814 shares (grant or award)
- 4 Grant or award Director acquired 2,325,581 shares (grant or award)
- 4 Grant or award Director acquired 250,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 10,000 shares (grant or award)
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- SC 13G Stake Amended Statement of Ownership
- 4 Shares withheld for taxes Sr. VP, Chief Business Officer gave up 3,969 shares (to pay taxes)
Page 44 of 62 · 1,224 filings